An Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia
An Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia
Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.
Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined exclusion criteria may apply.